A phase IA/IB trial of anti-CD3 murine monoclonal antibody plus low-dose continuous-infusion interleukin-2 in advanced cancer patients.

Sosman JA, Kefer C, Fisher RI, Jacobs CD, Pumfery P, Ellis TM
J Immunother Emphasis Tumor Immunol. 1995 17 (3): 171-80

PMID: 7613643 · DOI:10.1097/00002371-199504000-00006

MeSH Terms (13)

Adult Aged Antibodies, Anti-Idiotypic Antigens, CD Female Humans Interleukin-2 Killer Cells, Lymphokine-Activated Lymphocyte Count Male Middle Aged Muromonab-CD3 Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities:

Links